Improving Hand Use in Multiple Sclerosis
Rehabilitating Extremity Use After Multiple Sclerosis
1 other identifier
interventional
66
1 country
1
Brief Summary
This study will compare two different kinds of physical therapy to improve use of the hands in individuals with multiple sclerosis (MS). One treatment will be Constraint-Induced Movement therapy (CI therapy), the other will be a set of Complementary and Alternative Medicine (CAM) treatments (yoga, relaxation exercises, aquatherapy, massage). The study will determine which of the two forms of treatment is more successful for improving hand use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2 multiple-sclerosis
Started Feb 2010
Longer than P75 for phase_2 multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 4, 2010
CompletedFirst Posted
Study publicly available on registry
March 5, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedApril 15, 2015
April 1, 2015
6 years
March 4, 2010
April 14, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Motor Activity Log (MAL)
The MAL is a structured interview on the amount and quality of the more-affected hand use during daily living activities.
Before treatment, and immediately, 6 months, and 12 months after the end of treatment.
Secondary Outcomes (8)
Wolf Motor Function Test (WMFT)
Before treatment, and immediately, 6 months, and 12 months after the end of treatment.
MSFC (Multiple Sclerosis Composite Measure)
Before treatment, and immediately, 6 months, and 12 months after the end of treatment.
SARA (Scale for the Assessment and Rating of Ataxia)
Before treatment, and immediately, 6 months, and 12 months after the end of treatment.
EDSS (Expanded Disability Status Scale)
Before treatment, and immediately, 6 months, and 12 months after the end of treatment.
Fatigue Severity Scale (FSS)
Before treatment, and immediately, 6 months, and 12 months after the end of treatment.
- +3 more secondary outcomes
Study Arms (2)
CI Therapy
ACTIVE COMPARATORCI therapy involves repetitive practice with the more-affected hand on typical daily living activities (such as stacking objects, pouring, moving objects) for 3.5 hours per day, along with physical restraint of the better hand to keep it from assisting, and home practice exercises.
CAM treatments
ACTIVE COMPARATORCAM treatments are holistic physical treatments designed to work on the entire body to improve quality of life and overall health. This study will use yoga, relaxation exercises, aquatherapy (pool therapy), and massage.
Interventions
CI Therapy will be given for 3.5 hours per day, Monday-Friday, for 2 consecutive weeks.
CAM treatments will be given for 3.5 hours per day, Monday-Friday, for 2 consecutive weeks.
Eligibility Criteria
You may qualify if:
- diagnosis of non-relapsing multiple sclerosis (primary progressive MS, secondary progressive MS)
- reduced use of one of the hands because of MS
- ability to pick up and release a small object with the more-affected hand when requested
- can travel to the treatment program at the University of Alabama at Birmingham (UAB)
- can undergo treatment for 2 weeks (Monday-Friday), 3.5 hours per day
- can undergo MRI scan
- any kind of medication used for MS is allowed except spasticity medicine
You may not qualify if:
- disease relapse in the past 3 months
- pregnancy
- marked pain with arm movement
- severe uncontrolled medical illness
- simultaneous treatment with another form of physical therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35249, United States
Related Publications (3)
Mark VW, Taub E, Bashir K, Uswatte G, Delgado A, Bowman MH, Bryson CC, McKay S, Cutter GR. Constraint-Induced Movement therapy can improve hemiparetic progressive multiple sclerosis. Preliminary findings. Mult Scler. 2008 Aug;14(7):992-4. doi: 10.1177/1352458508090223. Epub 2008 Jun 23.
PMID: 18573826BACKGROUNDBarghi A, Allendorfer JB, Taub E, Womble B, Hicks JM, Uswatte G, Szaflarski JP, Mark VW. Phase II Randomized Controlled Trial of Constraint-Induced Movement Therapy in Multiple Sclerosis. Part 2: Effect on White Matter Integrity. Neurorehabil Neural Repair. 2018 Mar;32(3):233-241. doi: 10.1177/1545968317753073.
PMID: 29668401DERIVEDMark VW, Taub E, Uswatte G, Morris DM, Cutter GR, Adams TL, Bowman MH, McKay S. Phase II Randomized Controlled Trial of Constraint-Induced Movement Therapy in Multiple Sclerosis. Part 1: Effects on Real-World Function. Neurorehabil Neural Repair. 2018 Mar;32(3):223-232. doi: 10.1177/1545968318761050.
PMID: 29668399DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Victor W Mark, MD
University of Alabama at Birmingham
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 4, 2010
First Posted
March 5, 2010
Study Start
February 1, 2010
Primary Completion
February 1, 2016
Study Completion
March 1, 2016
Last Updated
April 15, 2015
Record last verified: 2015-04